In addition, tissues expressing high IFNA17 levels were negatively correlated with AR-responsive gene signatures, as revealed by GSEAs in TCGA prostate cancer datasets (GO, Nelson, Wang, PID; Fig. 4L). The gene discussed is MTA2; the disease is prostate carcinoma.